As of September 2025, GLP-1 prescriptions account for 6.5 out of every 100 prescriptions in the US
adults, are eligible for semaglutide therapy, the study states
10.1038/s41537-020-0093-9 106 MurphyL
While oral semaglutide has been available for diabetes (as Rybelsus), this approval makes Wegovy the first GLP-1 pill indicated for weight loss
The medication works by mimicking the action of the naturally occurring hormone GLP-1, which stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and reduces appetite through effects on the central nervous system
This package includes a 1ml ampoule and a 2ml syringe with a needle